PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.

shireesh apte

Loading [Contrib]/a11y/accessibility-menu.js

Editorial

Vol. 9, Issue 1, 2018

March 24, 2018 CDT

PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.

shireesh apte ,

hyaluronidase
pegph20
rhuph20
functional excipient
bioactive excipient

JEFC

apte, shireesh. 2018. “PEGylated Recombinant Human Hyaluronidase (PEGPH20): Transition from a Novel Functional Excipient to an API to Increase the Chemotherapeutic Effectiveness against Hyaluronan-Rich Cancers.” Journal of Excipients and Food Chemicals 9 (1).